Table 1 Clinical characteristics of patients at initiation of treatment
Clinical characteristics | rhGH n = 22 | GnRHa + GH n = 22 | AI + GH n = 24 | P |
|---|---|---|---|---|
Baseline age (years) | 13.0 ± 0.95 | 13.3 ± 0.94 | 12.9 ± 1.03 | > 0.05 |
Baseline bone age (years) | 14.0 ± 0.58 | 14.1 ± 0.41 | 14.1 ± 0.54 | > 0.05 |
Baseline height (cm) | 151.5 ± 2.99 | 151.3 ± 2.54 | 151.1 ± 2.12 | > 0.05 |
Baseline HtSDS-CA | -1.04 ± 0.95 | -1.23 ± 1.06 | -0.85 ± 0.98 | > 0.05 |
Baseline HtSDS-BA | -2.14 ± 0.29 | -2.14 ± 0.21 | -2.26 ± 0.31 | > 0.05 |
PHt | 161.7 ± 3.35 | 162.3 ± 1.75 | 161.6 ± 2.89 | > 0.05 |
THt | 169.7 ± 4.0 | 169.7 ± 3.9 | 169.1 ± 3.9 | > 0.05 |
IGF-1(nmol/L) | 56.2 ± 26.9 | 54.3 ± 20.6 | 57.4 ± 39.7 | > 0.05 |
TSH (mIu/L) | 2.79 ± 1.45 | 2.21 ± 1.02 | 2.01 ± 1.20 | > 0.05 |
T4(Pmol/L) | 14.7 ± 1.7 | 14.1 ± 2.3 | 14.4 ± 1.7 | > 0.05 |